172 related articles for article (PubMed ID: 16218880)
41. Pharmacotherapy for peripheral arterial disease: emerging therapeutic options.
Jaff MR
Angiology; 2002; 53(6):627-33. PubMed ID: 12463615
[TBL] [Abstract][Full Text] [Related]
42. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
43. Atherothrombosis--the neurologist's point of view.
Leys D
Vasc Med; 2001; 6(3 Suppl):17-9. PubMed ID: 11789962
[TBL] [Abstract][Full Text] [Related]
44. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
[TBL] [Abstract][Full Text] [Related]
45. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
[TBL] [Abstract][Full Text] [Related]
46. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
Rehring TF; Stolcpart RS; Hollis HW;
J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
[TBL] [Abstract][Full Text] [Related]
47. Current medical therapies for patients with peripheral arterial disease: a critical review.
Regensteiner JG; Hiatt WR
Am J Med; 2002 Jan; 112(1):49-57. PubMed ID: 11812407
[TBL] [Abstract][Full Text] [Related]
48. Intermittent claudication: a plea for guidelines for medical management.
Powell JT
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
[No Abstract] [Full Text] [Related]
49. Managing risk factors for atherosclerosis in critical limb ischaemia.
Gottsäter A
Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
[TBL] [Abstract][Full Text] [Related]
50. Medical therapy for peripheral arterial disease.
Simmons A; Steffen K; Sanders S
Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
[TBL] [Abstract][Full Text] [Related]
51. Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?
Mazhari R; Hsia J
Vasc Health Risk Manag; 2005; 1(2):111-7. PubMed ID: 17315397
[TBL] [Abstract][Full Text] [Related]
52. A critical review of antiplatelet treatment in peripheral arterial disease.
Violi F; Hiatt W
Intern Emerg Med; 2007 Jun; 2(2):84-7. PubMed ID: 17634816
[TBL] [Abstract][Full Text] [Related]
53. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
54. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
[TBL] [Abstract][Full Text] [Related]
55. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
Ferreira AC; Macedo FY
Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042
[TBL] [Abstract][Full Text] [Related]
56. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.
Mehler PS; Coll JR; Estacio R; Esler A; Schrier RW; Hiatt WR
Circulation; 2003 Feb; 107(5):753-6. PubMed ID: 12578880
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat".
Kiernan TJ; Hynes BG; Ruggiero NJ; Yan BP; Jaff MR
Tech Vasc Interv Radiol; 2010 Mar; 13(1):2-10. PubMed ID: 20123428
[TBL] [Abstract][Full Text] [Related]
58. Risk reduction with clopidogrel in the management of peripheral arterial disease.
Nayak KR; Cavendish JJ
Vasc Health Risk Manag; 2007; 3(3):289-97. PubMed ID: 17703636
[TBL] [Abstract][Full Text] [Related]
59. Peripheral arterial procedures and postinterventional prophylaxis.
Kröger K
J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
[No Abstract] [Full Text] [Related]
60. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
